June 18, 2020

New Report Highlights Urgent Need for Improved Treatments for Children with MDR-TB

Tuberculosis is a leading cause of death worldwide. Children with drug-resistant TB need improved treatment options
June 5, 2020

Standing Against Racism and Injustice

A Message to the TB Alliance Family
June 2, 2020

InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis

TB Alliance to leverage AlphaMeld, an AI-powered platform to capture and accelerate innovation to address unmet needs
May 28, 2020

TB Alliance Commercialization Partner, Mylan, Launches Named Patient Access Program for New Highly Resistant TB Treatment

The NPAP is designed for patients in countries where regulatory approval or other access mechanisms are not yet available
April 21, 2020

A Conversation with Mitchell Warren

How the TB Alliance Stakeholders Association Will Help Realize the Promise of New Therapies
February 12, 2020

TB Alliance Names Dr. Daniel Everitt Vice President and Chief Medical Officer

Dr. Everitt to lead development planning of novel drug regimens to treat tuberculosis
February 3, 2020

Jane Griffiths Joins TB Alliance Board of Directors

Griffiths has 35 years of experience in the healthcare industry
January 30, 2020

TB Research Funding Continues to Fall Short

Statement on 2019 G-FINDER Report